Conceptual Reference Database for Building Envelope Research Prev

From fungal exposure to disease: a biological monitoring conundrum

Biagini, R. E.
In "Bioaerosols, Fungi and Mycotoxins: Health Effects, Assessment, Prevention and Control", Edited by Johanning, E., Boyd Printing, Albany, New York
Biological Monitoring; Legacy Biomonitoring; Stachybotrys chartarum

Biagini, R. E., (2001), "From fungal exposure to disease: a biological monitoring conundrum", In "Bioaerosols, Fungi and Mycotoxins: Health Effects, Assessment, Prevention and Control", Edited by Johanning, E., Boyd Printing, Albany, New York.

Biological monitoring is the estimation of exposure to an agent through the measurement of biomarker(s) resulting from an internal dose of an agent. The biomarker(s) are typically the agent or its metabolite(s) in a biologically derived specimen. For example, styrene in expired air, styrene in blood, and mandelic and phenylglyoxylic acids (metabolites of styrene) in urine. The biomarker also can be a highly specific, validated effect of the agent, such as elevated levels of zinc protoporphyrin in blood caused by exposure to lead. Due to advances in molecular biology, genetics, analytical chemistry, and other basic sciences, it is now possible to detect smaller amounts of analytes and contaminants and smaller biological changes, as well as to identify mechanisms at the cellular and molecular levels. These advances can be exploited for biological monitoring, in some cases. Legacy biological monitoring, is the measurement of a specific biological monitoring determinant which contains none of the atoms of the molecule to which the organism was exposed. The most common example of this is an antibody produced against small molecular weight molecules or altered constituitive proteins. Numerous investigators have implicated putative exposure to macrocyclic tricothecenes and other compounds from Stachybotrys chartarum as being associated with a plethora of signs and symptoms of disease. To date, no compelling biological marker for exposure to Stachybotrys chartarum mycotoxins or other metabolites has been presented. There is no doubt that exposure to Stachybotrys chartarum is associated with an increased prevalence of self-reported symptoms. However, evidence of the association of these complaints with frank disease is lacking. More biological monitoring research is needed to solidify these associations, if present.

Related Resources:
  • This link has not been checked.Bioaerosols, Fungi and Mycotoxins, Ed. by Johanning, E.
    "papers presented at the September, 1998 Third International Conference in Saratoga Springs, New York. clinical and epidemiological studies and technical reports on an emerging public health topic affecting people in indoor environments at work and at home."

Related Concepts

Author Information and Other Publications Notes
Biagini, R. E.
  1. Manufacturing, classification, and selection of brick - classification, part 2
  2. Overview group on weathertightness of buildings
  3. Overview of building code requirements for masonry structures (ACI 530-02/ASCE 5-02/TMS 402-02) and Specification for Masonry Structures (ACI 530.1-02/ASCE 6-02/TMS 602-02)
  4. The relationship between symptoms and IgG and IgE antibodies in an office environment  

CRDBER, at CBS, BCEE, ENCS, Concordia,